Registered Name: Evrima Plc
Ticker: EVA
Registered Office: Hill Dickinson Llp, 8th Floor The Broadgate Tower, 20 Primrose Street, London, England, EC2A 2EW
ISIN: GB00BMDFKP05
Registration Number: 06474216
Incorporation: 16 January 2008
Shares in issue as at 11 Dec 2025 : 39,436,728 ordinary shares of 0.1 pence
Shares not held in public hands as at 11 Dec 2025:20,443,666 ordinary shares of 0.1 pence, 51.84% of enlarged issue share capital
Exchange: Aquis Stock Exchange
Significant Shareholders
| Shares Held | Percentage of enlarged | |
|---|---|---|
| Gledhow Investments | 3,700,000 | 9.38% |
| Mark Jackson | 2,928,084 | 7.42% |
| Pete Allaway | 2,475,582 | 6.28% |
| Andrew Neal | 1,200,000 | 3.03% |
Directors Share Holdings
| Shares Held | Percentage of enlarged | |
|---|---|---|
| S Grant-Rennick* | 5,540,000 | 14.05% |
| B Singh Tennent-Bhohi | 4,600,000 | 11.66% |
* Simon Grant-Rennick is an adviser to Alpha Corporate Services (Bermuda) Ltd. although he has no beneficial interest in that entity. Alpha Corporate Services (Bermuda) Ltd. hold 4,540,000 shares. Simon Grant-Rennick is interested in 1,000,000 shares.
Directors’ Options
| DIRECTOR | NUMBER OF OPTIONS HELD | VESTING CONDITIONS | STRIKE PRICE | EXPIRY |
|---|---|---|---|---|
| Burns Singh Tennent-Bhohi* | 1,000,000 | Vested | £0.10 | Sep-26 |
| (Chief Executive Officer) | ||||
| Simon Grant-Rennick* | 1.000.000 | Vested | £0.10 | Sep-26 |
| (Executive Chairman) | ||||
| David Eaton | 750,000 | Vested | £0.0125 | Apr-28 |
| (Non-Executive Director) | ||||
| Legacy Directors’ Options O/S | 900,000 | Vested | £0.04 | Jan-27 |
| 200,000 | Vested | £0.055 | Jun-28 | |
| 1,500,000 | Vested | £0.065 | Nov-27 | |
*Should Mr Singh Tennent-Bhohi and Mr Grant-Rennick exercise their options (in part or whole) on or before the life to expiry, they shall be issued replacement options on a one for one basis with a strike price of £0.20 and a life to expiry of 5-years from the date of admission of the exercised options
**Should the holders of 2,000,000 options elect to exercise their options (in part or whole) on or before the life to expiry, they shall be issued replacement options on a one for one basis with a strike price of £0.20 and a life to expiry of 5-years from the date of admission of the exercised options
Directors’ Warrants
| Director | Number of Warrants Held | Strike Price | Expiry |
|---|---|---|---|
| Burns Singh Tennent-Bhohi | 4,000,000 | £0.065 | Dec – 27* |
| (Chief Executive Officer) | |||
| Simon Grant-Rennick | 1,000,000 | £0.065 | Dec – 27* |
| (Executive Chairman) | |||
*Should the warrantholder elect to exercise their warrant entitlement in part or in whole, they shall be furnished a replacement warrant on a one for one basis with a strike price of £0.10 and a life to expiry of 5-years from admission of the exercised warrants
Outstanding Investor Warrants
| EVENT RELATING TO ISSUE | WARRANTS ISSUED | STRIKE PRICE | PROCEEDS IF EXERCISED | EXPIRY |
|---|---|---|---|---|
| Advisory / Performance (December 2022)* | 1,250,000 | £0.065 | £81,250.00 | 28/12/2027 |
| Performance Warrants** | 6,000,000 | £0.065 | £390,000.00 | 28/12/2027 |
*Should the underlying warrantholder elect to exercise their holding in whole or part on or before the life to expiry, the warrantholder on exercise shall receive a replacement warrant. The replacement warrant shall have a strike price of, £0.10 and a life to expiry of 5-years from date of admission of the warrant-shares exercised. If all warrantholders were to exercise their rights, a further 750,000 warrants would be issued.
**At the Company’s Annual General Meeting in December 2022, the Board proposed and the shareholders approved the creation of 6,000,000 Performance Warrants for which the Board have discretion to issue in circumstances whereby the Board believe performance has been of commercial benefit to the Company and its shareholders.
Fully Diluted Share Capital
As at 1 May 2025
| Issued Share Capital | 39,436,728 |
| Total Warrants Outstanding | 6,250,000* |
| Total Options Outstanding | 9,350,000 |
| Fully Diluted Share Capital | 55,036,728 |
*Performance Warrants Not Included as reserved for issue
FULLY DILUTED SHARE CAPITAL (should all replacement instruments be exercised)
| Fully Diluted Share Capital | 55,036,728 |
| Total Replacement Warrants Issued if All Warrants Exercised | 7,500,000 |
| Total Replacement Options Issued if All Options Exercised | 8,000,000 |
| Fully Diluted Share Capital Should All Instruments and Replacement Instruments be Exercised | 70,536,728 |
- Full Year Results 202530 Jun 2026
- Interims 202526 Sep 2025
- Full Year Results 202430 Jun 2025
- Interims 202408 Oct 2024
- Full Year Results 202321 Jun 2024
- Interims 202329 Sep 2023
- Full Year Results 202226 Jun 2023
- Interims 202226 Jun 2023
- Full Year Results 202122 Sep 2022
- Interims 202122 Sep 2022
- Full Year Results 202022 Sep 2022
- Interims 202022 Sep 2022
- Full Year Results 201922 Sep 2022
- Interims 201922 Sep 2022
- Full Year Results 201822 Sep 2022
- Interims 201822 Sep 2022
- Full Year Results 201722 Sep 2022
- Interims 201722 Sep 2022
- Form of Proxy – Annual General Meeting 202607 Aug 2026
- Notice of Annual General Meeting 202607 Aug 2026
- Annual General Meeting 202501 Jul 2025
- Annual General Meeting 202425 Jun 2024
- Annual General Meeting 202330 Jun 2023
- Annual General Meeting 202230 Nov 2022
- Annual General Meeting 202122 Sep 2022
- Annual General Meeting 202022 Sep 2022
- General Meeting 202022 Sep 2022
- Annual General Meeting 201922 Sep 2022
- General Meeting 201922 Sep 2022
- Annual General Meeting 201822 Sep 2022
